News - Progenics Pharmaceuticals


Current filters:

Progenics Pharmaceuticals

Popular Filters

Progenics buys Molecular Insight Pharma to expand oncology pipeline


USA-based Progenics Pharmaceuticals (Nasdaq: PGNX) revealed yesterday that it has acquired Molecular…

AzedraBiotechnologyMergers & AcquisitionsMolecular Insight PharmaceuticalsOncologyProgenics PharmaceuticalsTrofex

AstraZeneca's Brilinta gains Class I in ACCF/AHA Guidelines; enters deal with Progenics


Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced yesterday that a combined panel of experts…

Antibiotics and Infectious diseasesAstraZenecaBrilintaCardio-vascularLicensingMedImmunePharmaceuticalProgenics PharmaceuticalsRegulation

CytoDyn to acquire Progenics' PRO 140


Development-stage biotech firm CytoDyn (OTCQB: CYDY), has entered into a asset purchase agreement with…

Anti-viralsBiotechnologyCytoDynCytolinPRO 140Progenics Pharmaceuticals

Back to top